These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
279 related items for PubMed ID: 28775171
1. Gliosarcomas with the BRAF V600E mutation: a report of two cases and review of the literature. Wang L, Sun J, Li Z, Chen L, Fu Y, Zhao L, Liu L, Wei Y, Teng L, Lu D. J Clin Pathol; 2017 Dec; 70(12):1079-1083. PubMed ID: 28775171 [Abstract] [Full Text] [Related]
2. Gliosarcomas lack BRAFV600E mutation, but a subset exhibit β-catenin nuclear localization. Schwetye KE, Joseph NM, Al-Kateb H, Rich KM, Schmidt RE, Perry A, Gutmann DH, Dahiya S. Neuropathology; 2016 Oct; 36(5):448-455. PubMed ID: 26932501 [Abstract] [Full Text] [Related]
3. Co-occurrence of histone H3 K27M and BRAF V600E mutations in paediatric midline grade I ganglioglioma. Pagès M, Beccaria K, Boddaert N, Saffroy R, Besnard A, Castel D, Fina F, Barets D, Barret E, Lacroix L, Bielle F, Andreiuolo F, Tauziède-Espariat A, Figarella-Branger D, Puget S, Grill J, Chrétien F, Varlet P. Brain Pathol; 2018 Jan; 28(1):103-111. PubMed ID: 27984673 [Abstract] [Full Text] [Related]
4. A rare case of BRAF V600E-mutated epithelioid glioblastoma with a sarcomatous component. Ishikawa R, Kadota K, Hayashi T, Kimura N, Inoue K, Ibuki E, Kagawa S, Kushida Y, Okada M, Miyake K, Tamiya T, Nobusawa S, Hirato J, Haba R. Pathol Int; 2020 Mar; 70(3):166-170. PubMed ID: 31903645 [Abstract] [Full Text] [Related]
5. BRAF VE1 immunoreactivity patterns in epithelioid glioblastomas positive for BRAF V600E mutation. Kleinschmidt-DeMasters BK, Aisner DL, Foreman NK. Am J Surg Pathol; 2015 Apr; 39(4):528-40. PubMed ID: 25581727 [Abstract] [Full Text] [Related]
7. BRAF V600E Mutations Occur in a Subset of Glomus Tumors, and Are Associated With Malignant Histologic Characteristics. Karamzadeh Dashti N, Bahrami A, Lee SJ, Jenkins SM, Rodriguez FJ, Folpe AL, Boland JM. Am J Surg Pathol; 2017 Nov; 41(11):1532-1541. PubMed ID: 28834810 [Abstract] [Full Text] [Related]
9. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study. Rodriguez FJ, Scheithauer BW, Jenkins R, Burger PC, Rudzinskiy P, Vlodavsky E, Schooley A, Landolfi J. Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476 [Abstract] [Full Text] [Related]
10. Adult classical glioblastoma with a BRAF V600E mutation. Takahashi Y, Akahane T, Sawada T, Ikeda H, Tempaku A, Yamauchi S, Nishihara H, Tanaka S, Nitta K, Ide W, Hashimoto I, Kamada H. World J Surg Oncol; 2015 Mar 11; 13():100. PubMed ID: 25885250 [Abstract] [Full Text] [Related]
11. Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells. Koelsche C, Wöhrer A, Jeibmann A, Schittenhelm J, Schindler G, Preusser M, Lasitschka F, von Deimling A, Capper D. Acta Neuropathol; 2013 Jun 11; 125(6):891-900. PubMed ID: 23435618 [Abstract] [Full Text] [Related]
12. Primary and secondary gliosarcomas: clinical, molecular and survival characteristics. Cachia D, Kamiya-Matsuoka C, Mandel JJ, Olar A, Cykowski MD, Armstrong TS, Fuller GN, Gilbert MR, De Groot JF. J Neurooncol; 2015 Nov 11; 125(2):401-10. PubMed ID: 26354773 [Abstract] [Full Text] [Related]
13. BRAF V600E expression and distribution in desmoplastic infantile astrocytoma/ganglioglioma. Koelsche C, Sahm F, Paulus W, Mittelbronn M, Giangaspero F, Antonelli M, Meyer J, Lasitschka F, von Deimling A, Reuss D. Neuropathol Appl Neurobiol; 2014 Apr 11; 40(3):337-44. PubMed ID: 23822828 [Abstract] [Full Text] [Related]
14. Combined pleomorphic xanthoastrocytoma-ganglioglioma with BRAF V600E mutation: case report. Cicuendez M, Martinez-Saez E, Martinez-Ricarte F, Asanza EC, Sahuquillo J. J Neurosurg Pediatr; 2016 Jul 11; 18(1):53-7. PubMed ID: 27015517 [Abstract] [Full Text] [Related]
15. Frequency of BRAF V600E mutations in 969 central nervous system neoplasms. Behling F, Barrantes-Freer A, Skardelly M, Nieser M, Christians A, Stockhammer F, Rohde V, Tatagiba M, Hartmann C, Stadelmann C, Schittenhelm J. Diagn Pathol; 2016 Jun 27; 11(1):55. PubMed ID: 27350555 [Abstract] [Full Text] [Related]
16. Pilocytic astrocytoma vs. ganglioglioma: Progression vs. misdiagnosis, and implications in BRAF testing. Yoon J, Cusimano M, Munoz DG. J Clin Neurosci; 2019 Aug 27; 66():231-234. PubMed ID: 31147230 [Abstract] [Full Text] [Related]
17. Longitudinal mutational analysis of a cerebellar pilocytic astrocytoma recurring as a ganglioglioma. Fiset PO, Fontebasso AM, De Jay N, Gayden T, Nikbakht H, Majewski J, Jabado N, Albrecht S. Pediatr Blood Cancer; 2017 Feb 27; 64(2):275-278. PubMed ID: 27718322 [Abstract] [Full Text] [Related]
18. [BRAF V600E mutation and clinicopathologic characteristics in 250 cases of brain tumors associated with epilepsy]. Qi XL, Yao K, Duan ZJ, Bian Y, Ma Z, Piao YS, Gong LP. Zhonghua Bing Li Xue Za Zhi; 2018 Sep 08; 47(9):664-670. PubMed ID: 30220118 [Abstract] [Full Text] [Related]
19. BRAF V600E mutation is a significant prognosticator of the tumour regrowth rate in brainstem gangliogliomas. Chen X, Pan C, Zhang P, Xu C, Sun Y, Yu H, Wu Y, Geng Y, Zuo P, Wu Z, Zhang J, Zhang L. J Clin Neurosci; 2017 Dec 08; 46():50-57. PubMed ID: 28986151 [Abstract] [Full Text] [Related]
20. Intramedullary gangliogliomas: histopathologic and molecular features of 25 cases. Gessi M, Dörner E, Dreschmann V, Antonelli M, Waha A, Giangaspero F, Gnekow A, Pietsch T. Hum Pathol; 2016 Mar 08; 49():107-13. PubMed ID: 26826417 [Abstract] [Full Text] [Related] Page: [Next] [New Search]